We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

Louis Navellier is a prominent American investor, author, and financial analyst, best known for his quantitative approach to ...

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...

Carrier Global Corporation, a leading provider of intelligent climate and energy solutions, announced the appointment of Amy E. Miles as an independent director to its Board of Directors. Effective ...

Amgen successfully launched two next-generation products, Aranesp and Neulasta. Meanwhile, the acquisition of Immunex Corporation gave Amgen access to the multi-blockbuster drug, Enbrel. However, all ...

Drug discovery is a key area for AI, given the speed at which models trained on massive datasets can tackle a variety of tasks. Last year, Nvidia said it was doubling down on AI-powered drug discovery ...

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Hold rating on Incyte (INCY – Research Report), with a ...

Dominic Marasco, RPh, joins the company as President, Endocrine Business Unit, effective January 6, 2025DANBURY, Conn. and WESTLAKE VILLAGE, ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp. (MSFT), Exxon Mobil ...

Central Pacific Bank Trust Division lessened its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 82.3% in the 4th ...

Jai Corp share price saw a sharp decline on Thursday, January 2, plunging to its 52-week low of ₹247.90, after hitting the 20% lower circuit limit, accompanied by heavy trading volumes.

Here's why Amgen increased its land holdings in New Albany, even though the pharma giant has plenty of room for expansion on ...